Phosphoinositide 3-kinase delta (PI3Kδ) in leukocyte signaling and function

被引:88
|
作者
Fung-Leung, Wai-Ping [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Dept Immunol, San Diego, CA 92121 USA
关键词
PI3K delta; Lipid kinase; Signaling; Leukocyte; Inflammation; Autoimmune disease; CELL CYTOKINE PRODUCTION; B-CELL; CUTTING EDGE; PHOSPHATIDYLINOSITOL; 3-KINASE; P110-DELTA; PI3K; P110-GAMMA; ISOFORM; ACTIVATION; MECHANISMS;
D O I
10.1016/j.cellsig.2010.10.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
PI3K delta is a lipid kinase of the PI3K class IA family involved in early signaling events of leukocytes responding to a wide variety of stimuli. The leukocyte specificity of PI3K delta is defined by its expression, whereas its signaling function is via the production of phosphoinositide 3,4,5-triphosphates at the proximity of activated receptors for recruiting other signaling molecules. The importance of PI3K delta in B cell development and function is most apparent, and its role in other leukocyte cell types can be easily demonstrated as well. PI3K delta participates in the development, activation and migration of T cells and NK cells. The role of PI3K delta in myeloid cell activities, such as inflammation driven cell infiltration, neutrophil oxidative burst, immune complex mediated macrophage activation, as well as mast cell maturation and degranulation, has been well illustrated in various studies. As a result of the broad effects of PI3K delta in leukocyte functions, the disruption of PI3K delta expression or activity leads to decreased inflammatory and immune responses in vivo. The protective role of PI3K delta inactivation in animal models of arthritis, asthma or obstructive respiratory diseases has been demonstrated. These findings suggest the potential efficacy achievable with PI3K delta inhibitors in the treatment of autoimmune and respiratory diseases. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:603 / 608
页数:6
相关论文
共 50 条
  • [41] Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinase α (PI3Kα) inhibitors
    Wu, Peng
    Su, Yi
    Liu, Xiaowen
    Yang, Bo
    He, Qiaojun
    Hu, Yongzhou
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (09) : 2837 - 2844
  • [42] Discovery of the Potent Phosphoinositide 3-Kinase δ (PI3 K δ) Inhibitors
    Lei, Tao
    Hong, Yongwei
    Chang, Xinyue
    Zhang, Zhimin
    Liu, Xingguo
    Hu, Miao
    Huang, Wenhai
    Yang, Haiyan
    [J]. CHEMISTRYSELECT, 2020, 5 (01): : 196 - 200
  • [43] case of activated phosphoinositide 3-kinase (PI3K) delta syndrome associated with growth hormone deficiency, aseptic arthritis, nephromegaly, and asthma
    Craig, Megan
    Cernelc-Kohan, Mateja
    Wigby, Kristen
    Phillips, Susan
    Geng, Bob
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S88 - S88
  • [44] Novel 6-aryl substituted 4-pyrrolidineaminoquinazoline derivatives as potent phosphoinositide 3-kinase delta (PI3Kδ) inhibitors
    Xin, Minhang
    Duan, Weiming
    Feng, Yifan
    Hei, Yuan-Yuan
    Zhang, Hao
    Shen, Ying
    Zhao, Hong-Yi
    Mao, Shuai
    Zhang, San-Qi
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (08) : 2028 - 2040
  • [45] Phosphoinositide 3-kinase (PI3K) inhibition modulates responses to rhinovirus by mechanisms that are predominantly independent of autophagy
    Ismail, S.
    Roberts, R. L.
    Stokes, C. A.
    Juss, J. K.
    Sabroe, I.
    Parker, L. C.
    [J]. IMMUNOLOGY, 2013, 140 : 84 - 85
  • [46] SELECTIVE INHIBITION OF PHOSPHOINOSITIDE 3-KINASE (PI3K)γ IS NEUROPROTECTIVE IN A RAT MODEL OF SURGICAL BRAIN INJURY
    Huang, L.
    Sherchan, P.
    Applegate, R.
    Martin, R. D.
    Zhang, J.
    [J]. ANESTHESIA AND ANALGESIA, 2014, 118 : S159 - S159
  • [47] Nonradioactive quantification of phosphoinositide 3-kinase (PI3K) products from breast cancer cell lines
    Ehrmantrout, Kimberly
    Thompson, James
    Neilsen, Paul
    Branch, Angie
    [J]. CANCER RESEARCH, 2009, 69
  • [48] Which comes first, "the chicken or the egg" - alterations in arterial Phosphoinositide 3-Kinase (PI3K) or hypertension?
    Northcott, CA
    Watts, SW
    [J]. FASEB JOURNAL, 2004, 18 (05): : A977 - A977
  • [49] Targeting phosphoinositide 3-kinase γ (PI3Kγ) in the treatment of cutaneous leishmaniasis caused by L. mexicana
    Cummings, Hannah Elizabeth
    Barbi, J.
    Keiser, T.
    Zorko, N.
    Lu, B.
    Gerard, C.
    Ruckle, T.
    Seveau, S.
    Rommel, C.
    Whitacre, C.
    Satoskar, A.
    [J]. FASEB JOURNAL, 2008, 22
  • [50] Phosphoinositide 3-Kinase (PI3K) Pathway Alterations Are Associated with Histologic Subtypes and Are Predictive of Sensitivity to PI3K Inhibitors in Lung Cancer Preclinical Models
    Spoerke, Jill M.
    O'Brien, Carol
    Huw, Ling
    Koeppen, Hartmut
    Fridlyand, Jane
    Brachmann, Rainer K.
    Haverty, Peter M.
    Pandita, Ajay
    Mohan, Sankar
    Sampath, Deepak
    Friedman, Lori S.
    Ross, Leanne
    Hampton, Garret M.
    Amler, Lukas C.
    Shames, David S.
    Lackner, Mark R.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (24) : 6771 - 6783